In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Qinglan Bao; Xiaoxiao Zhang; Yingsong Chen; Tegexibaiyin Wang; Bateer Siqin

doi:10.3791/66810

Моделирование in vitro отложения жира при стеатозном заболевании печени, ассоциированном с метабо...

JoVE Journal
Biology

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Biology

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Моделирование in vitro отложения жира при стеатозном заболевании печени, ассоциированном с метаболической дисфункцией

Full Text

1,929 Views

07:03 min

July 19, 2024

DOI: 10.3791/66810-v

Qinglan Bao¹, Xiaoxiao Zhang², Yingsong Chen*^1,3,4, Tegexibaiyin Wang*⁵, Bateer Siqin*⁶

¹Inner Mongolia Medical University, ²Xilin Gol League Mongolian Medical Hospital, ³National and local Joint Mongolian Medicine R & D Engineering Center, ⁴Inner Mongolia Minzu University, ⁵Affiliated Hospital of Inner Mongolia Minzu University, ⁶Traditional Chinese & Mongolian Medical Research Institute of Inner Mongolia

Please note that some of the translations on this page are AI generated. Click here for the English version.

Overview

This study investigates the use of oleic acid-induced HepG2 cells as a model for metabolic dysfunction-associated steatotic liver disease. By analyzing the effects of oleic acid on these cells, the research aims to elucidate the mechanisms underlying this liver condition.

Key Study Components

Research Area

Metabolic dysfunction-associated steatotic liver disease
Effect of oleic acid on liver cells
Traditional Mongolian medicine therapy

Background

Importance of studying metabolic liver diseases
Use of HepG2 cells as a model system
Previous findings on fatty liver disease mechanisms

Methods Used

Cell culture and treatment with oleic acid
Assessment of lipid content via Oil Red O staining and triglyceride measurements
Optical density measurements using a microplate reader

Main Results

Oleic acid treatment decreased cell survival rates at higher concentrations
Significant increase in lipid droplet formation in treated HepG2 cells
Elevated total triglycerides in cell supernatants post-treatment

Conclusions

The study successfully establishes a cell model for investigating steatotic liver disease.
Findings highlight the impact of oleic acid on lipid accumulation in liver cells, informing future therapeutic strategies.

Frequently Asked Questions

What is the significance of studying HepG2 cells?

HepG2 cells are a widely used human liver cell line that serves as an important model for studying liver-related metabolic diseases.

How does oleic acid affect HepG2 cells?

Oleic acid treatment leads to increased lipid droplet formation and reduced cell viability at higher concentrations.

What methods were used to assess lipid content?

Lipid content was measured using Oil Red O staining and total triglyceride assays, with optical density readings taken with a microplate reader.

What future studies are planned?

Future studies aim to explore the mechanisms of action of various therapies on the established cell model.

How can this study inform traditional medicine?

Insights from this research may enhance the understanding of traditional Mongolian medicine’s role in treating liver diseases.

What were the main findings of the study?

The study found that oleic acid promotes lipid accumulation in HepG2 cells, indicating potential pathways for metabolic disease interventions.

В данной статье описывается использование клеток HepG2, индуцированных олеиновой кислотой, в качестве модели стеатотического заболевания печени, связанного с метаболической дисфункцией.

Нашим направлением исследований является изучение традиционной монгольской медицины путем создания клеточной модели стеатотической болезни печени, связанной с метаболической дисфункцией. Изучена роль и механизм кумысотерапии. Результаты исследования присутствия окажутся полезными в будущем, что позволит создать модели клеток стеатотического заболевания печени, связанного с метаболической дисфункцией, и исследовать механизмы, лежащие в основе заболевания.

Будущее исследование будет проведено на основе модели клеточной модели стеатического заболевания печени, ассоциированного с метаболической дисфункцией, чтобы изучить механизм действия гиполипидемического эффекта кумыса.

View the full transcript and gain access to thousands of scientific videos